IP Library Granted Patent US 10,538,771
Granted Patent B2
US 10,538,771 · App. 16/118,596 · Granted Jan 21, 2020

Compositions and methods for detecting microorganisms

Inventors: Urs A. Ochsner (Boulder, CO); Nebojsa Janjic (Boulder, CO)
Assignee: SomaLogic, Inc.
C12N15/115C12N15/1048C12Q1/14G01N33/5308G01N33/569C12N2310/16G01N2333/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,538,771
App. No.
16/118,596
Granted
Jan 21, 2020
Kind
B2
Abstract

Described herein are compositions and methods for detecting the presence or absence of a microorganism in a sample comprising contacting the sample with an aptamer capable of binding to a cell-surface protein of the microorganism to form a complex, contacting the mixture with a second aptamer capable of binding to the first cell-surface protein or a second cell-surface protein of the microorganism; and performing an assay to detect the second aptamer, wherein detecting the second aptamer indicates that the microorganism is present in the sample, and wherein not detecting the second aptamer indicates that the microorganism is absent from the sample.

Claims (4)

1. A nucleic acid molecule comprising the sequence of SEQ ID NOs: 10-12, wherein n is independently, for each occurrence, a C-5 modified pyrimidine selected from the group consisting of 5-(N-benzylcarboxyamide)-2′-deoxycytidine (BndC); 5-(N-2-phenylethylcarboxyamide-2′-deoxycytidine (PEdC); 5-(N-3-phenylpropylcarboxyamide)-2′-deoxycytidine (PPdC); 5-(N-1-naphthylmethylcarboxyamide-2′-deoxycytidine (NapdC); 5-(N-2-naphthylmethylcarboxyamide)-2′-deoxycytidine (2NapdC); 5-(N-1-naphthyl-2-ethylcarboxyamide)-2′-deoxycytidine (NEdC); 5-(N-2-naphthyl-2-naphthyl-2-ethylcarboxyamide)-2′-deoxycytidine (2NEdC); 5-(N-benzylcarboxyamide)-2′-deoxyuridine (BndU); 5-(N-isobutylcarboxyamide-2′-deoxyuridine (iBudU); 5-(N-tryptaminocarboxyamide-2′-deoxyuridine (TrpdU); 5-(N-[1-(3-trimethylamonium) propyl]carboxyamide)-2′-deoxyuridine chloride and 5-(N-naphthylmethylcarboxyamide)-2′-deoxyuridine (NapdU), wherein the nucleic acid molecule is from about 40 to about 100 nucleotides in length.

2. The nucleic acid molecule of claim 1 , wherein C-5 modified pyrimidine is a 5-(N-benzylcarboxyamide)-2′-deoxyuridine (BndU).

3. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule has affinity for a ClfA protein.

4. A kit for detecting the presence or absence of a microorganism in a sample comprising a nucleic acid molecule of claim 1 .

Assignments (2)
CHANGE OF NAME Recorded Feb 4, 2022
From: SOMALOGIC INC.
To: SOMALOGIC OPERATING CO. INC.
Reel/Frame 058885/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2018
From: OCHSNER, URS A.; JANJIC, NEBOJSA
To: SOMALOGIC, INC.
Reel/Frame 046767/0983 →
Continuity (4)
Division 15112739
Provisional Application 61940955 · Feb 18, 2014
Provisional Application 61947627 · Mar 4, 2014
Related Publication 20180371462A1 · Dec 27, 2018